Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of Human Senescent Cell Biomarkers for Clinical Trials

Aging Cell(2025)10.1111/acel.14489Source: DataRank Database

Characterization of Human Senescent Cell Biomarkers for Clinical Trials is a research paper published in Aging Cell (2025). On theSindex it has a DataRank of 0.531. It has been cited 16 times, with 14 citing works in its 1-hop citation network.

N/A

0.531DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access16 citations · 14 citing works in its network

Download PDF

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT04313634

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: gold

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 80%Citation Network 20%

Base Score Contribution

0.425

From this paper's citation signal

Citation Network Contribution

0.106

From 9 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 14 citers.

Disrupted immune senescence in early pregnancy is associated with recurrent pregnancy loss
Frontiers in Immunology20261 citations35 referencesContributes 0.020
Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
Frontiers in Immunology20252 citations59 referencesContributes 0.019
Senotherapeutics for Brain Aging Management
Neurology International20259 citations126 referencesContributes 0.018
Functional Features of Senescent Cells and Implications for Therapy
International Journal of Molecular Sciences20257 citations123 referencesContributes 0.017
Therapy-Induced Senescence (TIS) and SASP: The p53-Mediated Interplay in Cancer Progression and Treatment
International Journal of Molecular Sciences20255 citations127 referencesContributes 0.014

Authors (7)

David G. Monroe ORCID,Elizabeth J. Atkinson ORCID,Mitchell N. Froemming,Ming Ruan,Nathan K. LeBrasseur ORCID

Live enrichment

National Institute on Aging

Grant: P01 AG062413

National Institute on Aging

Grant: R01 AG076515

National Institute on Aging

Grant: R01 AG086085

National Institute on Aging

Grant: R21 AG065868

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01 DK128552

goldLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.14489

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/acel.14489

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12073900/pdf/ACEL-24-e14489.pdf

Related Papers (10)

Guidelines for minimal information on cellular senescence experimentation in vivo

Cell(2024)

co-cited

10.1016/j.cell.2024.05.059

Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial

N/A

1.7DataRank · unranked

Nature Medicine(2024)

co-cited

10.1038/s41591-024-03096-2

Cellular senescence and senolytics: the path to the clinic

Nature Medicine(2022)

co-cited

10.1038/s41591-022-01923-y

SenNet recommendations for detecting senescent cells in different tissues

N/A

4.6DataRank · unranked

Nature Reviews Molecular Cell Biology(2024)

co-cited

10.1038/s41580-024-00738-8

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability

EBioMedicine(2023)

co-cited

10.1016/j.ebiom.2023.104481

Senolytic CAR T cells reverse senescence-associated pathologies

N/A

7.8DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2403-9

Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice

Aging Cell(2021)

co-citedsame journal

10.1111/acel.13296

A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues

N/A

1.0DataRank · unranked

Nature Communications(2022)

co-cited

10.1038/s41467-022-32552-1

p53 in ferroptosis regulation: the new weapon for the old guardian

N/A

0.940DataRank · unranked

Cell Death and Differentiation(2022)

co-cited

10.1038/s41418-022-00943-y

Cancer neuroscience: State of the field, emerging directions

Cell(2023)

co-cited

10.1016/j.cell.2023.02.002